glp-1 news today Can one drug do it all? Reviewing the expanding clinical universe of agonists GLP-1 Weight-Loss Drug Demonstration Begins

And with addiction, more than any other disease, the number of deaths averted captures just a piece of the devastating cascade of downstream consequences that tear apart families, communities, and entire countries

Liraglutide administration did not reduce general food intake during baseline or produce motor suppression, highlighting behavioral specificity

In a 2023 case report, a 31-year-old appropriately fasted female on Ozempic was found to have significant amounts of solid food in her stomach during endoscopy

Its important to think about possible side effects and talk to a healthcare provider if needed

Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascularrisk in type 2 diabetes mellitus